166 related articles for article (PubMed ID: 26692937)
1. Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
Fei C; Guo J; Zhao Y; Gu S; Zhao S; Li X; Chang C
Am J Transl Res; 2015; 7(10):1939-51. PubMed ID: 26692937
[TBL] [Abstract][Full Text] [Related]
2. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
[TBL] [Abstract][Full Text] [Related]
3. Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway.
Guo J; Fei C; Zhao Y; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Oncotarget; 2017 Aug; 8(33):55405-55421. PubMed ID: 28903429
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
5. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA BDNF-AS modulates osteogenic differentiation of bone marrow-derived mesenchymal stem cells.
Feng X; Lin T; Liu X; Yang C; Yang S; Fu D
Mol Cell Biochem; 2018 Aug; 445(1-2):59-65. PubMed ID: 29247276
[TBL] [Abstract][Full Text] [Related]
7. γ-Secretase inhibitor reverts the Notch signaling attenuation of osteogenic differentiation in aged bone marrow mesenchymal stem cells.
Tang Z; Wei J; Yu Y; Zhang J; Liu L; Tang W; Long J; Zheng X; Jing W
Cell Biol Int; 2016 Apr; 40(4):439-47. PubMed ID: 26801333
[TBL] [Abstract][Full Text] [Related]
8. Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the β-catenin pathway.
Yu Z; Fan L; Li J; Ge Z; Dang X; Wang K
Int J Mol Med; 2015 Nov; 36(5):1264-72. PubMed ID: 26352537
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway.
Li X; Guo L; Liu Y; Su Y; Xie Y; Du J; Zhou J; Ding G; Wang H; Bai Y; Liu Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):928-933. PubMed ID: 28943430
[TBL] [Abstract][Full Text] [Related]
11. [Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes].
Fei CM; Gu SC; Zhao YS; Guo J; Li X; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):750-5. PubMed ID: 26117031
[TBL] [Abstract][Full Text] [Related]
12. Melatonin Rescues the Ti Particle-Impaired Osteogenic Potential of Bone Marrow Mesenchymal Stem Cells via the SIRT1/SOD2 Signaling Pathway.
Zhang Y; Zhu X; Wang G; Chen L; Yang H; He F; Lin J
Calcif Tissue Int; 2020 Nov; 107(5):474-488. PubMed ID: 32767062
[TBL] [Abstract][Full Text] [Related]
13. Clonal MDS/AML cells with enhanced TWIST1 expression reprogram the differentiation of bone marrow MSCs.
Li H; Wang Y; Yang F; Feng S; Chang K; Yu X; Guan F; Li X
Redox Biol; 2023 Nov; 67():102900. PubMed ID: 37748319
[TBL] [Abstract][Full Text] [Related]
14. Impaired osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with lower-risk myelodysplastic syndromes.
Fei C; Zhao Y; Gu S; Guo J; Zhang X; Li X; Chang C
Tumour Biol; 2014 May; 35(5):4307-16. PubMed ID: 24443267
[TBL] [Abstract][Full Text] [Related]
15. Effects of CD4
Shao BY; Wang L; Yu Y; Chen L; Gan N; Huang WM
Exp Ther Med; 2020 Nov; 20(5):84. PubMed ID: 32968441
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.
Fei CM; Guo J; Zhao YS; Zhao SD; Zhen QQ; Shi L; Li X; Chang CK
J Transl Med; 2018 Aug; 16(1):234. PubMed ID: 30143008
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.
Kim M; Hwang S; Park K; Kim SY; Lee YK; Lee DS
PLoS One; 2015; 10(3):e0120602. PubMed ID: 25803272
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-Catenin Pathway Is Involved in Cadmium-Induced Inhibition of Osteoblast Differentiation of Bone Marrow Mesenchymal Stem Cells.
Wu L; Wei Q; Lv Y; Xue J; Zhang B; Sun Q; Xiao T; Huang R; Wang P; Dai X; Xia H; Li J; Yang X; Liu Q
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917596
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.
Yoshioka S; Miura Y; Yao H; Satake S; Hayashi Y; Tamura A; Hishita T; Ichinohe T; Hirai H; Takaor-Kondo A; Maekawa T
Stem Cells; 2014 Mar; 32(3):730-40. PubMed ID: 24115241
[TBL] [Abstract][Full Text] [Related]
20. [Spermidine enhances osteogenic differentiation and inhibits adipogenic differentiation of bone marrow-derived mesenchymal stem cells from ovariectomized mice].
Qi M; Liu W; Ma Y; Yang Y; Jin Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):787-91. PubMed ID: 26062423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
